Hyesoo Lowe, MD

Medical Director of the Thyroid Biopsy Program

Hyesoo Lowe, MD

Appointment Phone:

212-305-0078

Primary Locations:

Herbert Irving Pavilion
161 Fort Washington Ave, 8th Fl
New York, NY 10032
Fax: 212-305-5992

Appointments:

Assistant Professor of Medicine

About:

Hyesoo Lowe, MD is the medical director of the Thyroid Biopsy Program at the Columbia Thyroid Center. She is a board certified endocrinologist with a special interest in thyroid disorders including thyroid nodules, thyroid cancer, autoimmune thyroid disease, and thyroid illnesses in pregnancy. After graduating from Weill Cornell Medical College, she completed an internship and residency in Internal Medicine at the Yale School of Medicine, and a Fellowship in Endocrinology, Diabetes and Metabolism at Columbia University Irving Medical Center. She is a member of the American Thyroid Association, the Endocrine Society and the American Association of Clinical Endocrinologists.

Dr. Lowe is committed to providing compassionate and individualized care according to her patients' unique needs. She has been recognized as a Castle Connolly Top Doctor for the New York metro area, listed in Castle Connolly's Exceptional Women in Medicine, featured among New York magazine’s Top Doctors, and given the honor of vitals.com’s Compassionate Doctor award and Patient's Choice award.

Dr. Lowe is proficient in Spanish and Korean.

Education:

  • MD: Cornell University Medical College
  • BA: Cornell University
  • Fellowship: Columbia University Medical Center
  • Residency: Yale School of Medicine
  • Internship: Yale School of Medicine

Honors:

  • Castle Connolly Top Doctors, New York Metro Area, New York Magazine (2017, 2018, 2019)
  • Castle Connolly Exceptional Women in Medicine (2017, 2018, 2019)
  • Top Docs, New Jersey Monthly (2017, 2018, 2019)
  • Top Doctors, Inside Jersey (2017, 2018, 2019)
  • Top Doctors, Bergen Magazine (2017, 2018, 2019)
  • Vitals.com Compassionate Doctor Award (2010-2018)
  • Vitals.com Patient’s Choice Award (2010-2018)
  • Vitals.com Top 10 Doctor (2014)
  • Department of Veterans Affairs Special Contribution Award for unique contribution to the mission of the Department; Participated in pilot program to transition out-patient clinic to open-access model (2004)
  • Yale School of Medicine Power Day Award: Chosen for modeling the responsible, positive, and beneficial use of power in health care relationships (2003)
  • David P. Barr Research Fellow (1997)

Publications:

Peer-Reviewed Research Publications

  • Lowe H, Cusano NE, Binkley N, Blaner WS, Bilezikian JP. Vitamin D toxicity due to a commonly available “over the counter” remedy from the Dominican Republic. J Clin Endocrinol Metab (2011) 96(2):291-5.
  • Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, Sacco RL, Silverberg SJ. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: The Northern Manhattan Study. Stroke (2011) 42:2240-45.
  • Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab (2007) 92(8):3001-5.

BOOK CHAPTERS

  • Lowe H, Shane E. Osteoporosis associated with illness and medications. In: Marcus, Feldman, Nelson, Rosen, eds. Osteoporosis, 3rd Ed. San Diego, CA: Elsevier; 2007.

ABSTRACTS

  • Lowe H, McMahon DJ, Walker MD, Rubin M, Bilezikian J, Silverberg SJ (2008). Normocalcemic primary hyperparathyroidism: Update on a new clinical phenotype. J Bone Min Res 23(Suppl 1) SA486.
  • Lowe H, Binkley N, Blaner, WS, Plum LA, Bilezikian JP (2008). Vitamin D toxicity due to a commonly available remedy from the Dominican Republic. J Bone Min Res 23 (Suppl 1) SU195.
  • Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2006). Normocalcemic primary hyperparathyroidism: further characterization and short term natural history. J Bone Min Res 21 (Suppl 1) S37.
  • Lowe H, Feldman L, Aslan M, Caulin-Glaser T, Howes C, Gulanski B (2003). The association of endogenous androgen levels with metabolic risk factors for coronary heart disease in postmenopausal women. Poster presented at The Endocrine Society 85th Annual Meeting, 2003; Philadelphia, PA. Poster P2-195.